To disseminate the findings generated in VALUE-Dx by using various forms of communication and educational activities and publications at all levels of stakeholder platforms to promote their uptake and implementation in daily clinical practice and policy
To develop innovative, effective ways to disseminate information for creating awareness of optimal diagnosis and prognosis of CA-ARTI to prevent unnecessary prescription and use of antibiotics, to improve coverage with antibiotics, and thus limit antibiotic resistance and associated health and socioeconomic impacts
To develop and to tailor materials to support the adoption of CA-ARTI-Dx in European community care settings
Read our interview with Professor Bojana Beović from the Ljubljana University Medical Centre. She elaborates on her role in the antimicrobial resistance (AMR) field, the impact of the COVID-19 pandemic on AMR and its research.
https://www.value-dx.eu/wp-content/uploads/2022/04/bojana-beovic.jpg13652048Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2022-07-29 14:17:232022-08-01 13:39:59Interview with Professor Bojana Beović
https://www.value-dx.eu/wp-content/uploads/2022/07/Value-dx-ecraid-press-release-image.png10801920Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2022-07-14 07:29:452022-07-14 07:29:45Ecraid press release on European response to monkeypox virus outbreak
https://www.value-dx.eu/wp-content/uploads/2022/07/VALUE-Dx-publication-image.jpg10801657Leandrahttps://www.value-dx.eu/wp-content/uploads/2019/07/Logo-300x124.pngLeandra2022-07-12 12:30:242022-07-14 07:38:21POC Diagnostics in General Practice: the Effects on Antimicrobial Resistance